Diagnosis and treatment of somatoform autonomous functional disorders - A literature review;Somatoforme autonome funktionsstörungen - Diagnostik und therapie - Eine übersicht der empirischen literatur

Zeitschrift fur Psychosomatische Medizin und Psychotherapie

Volumn 44, Issue 2, 1998, Pages 108-126

  Loew, Thomas ^a   Hartkamp, Norbert ^b   Leibing, Eric ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

Autonomous functional; Body Complaints; Diagnosis; Review; Somatoform Disorders; Treatment

Indexed keywords

COMORBIDITY; FEEDBACK SYSTEM; HUMAN; NEUROSIS; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; PSYCHOTHERAPY; REVIEW;

EID: 0031924862     PISSN: 14383608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Alevizos, B., Christodoulou, G. N., Ioannidis, C., Voulgari, A., Mantidis, A., Spiliadis, C. (1989): The efficacy of amineptine in the treatment of depressive patients with irritable bowel syndrome. Clinical Neuropharmacology 12 Suppl.2, 66-76.
2. Arthurs, Y., Fielding, J. F. (1983): Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome. Irish Medical Journal 76, 253.
3. Award, R., Dibildox, M., Ortiz, F. (1995): Irritable bowel syndrome treatment using pinaverium bromide as a calcium channel blocker. A randomized double-blind placebo-controlled trial. Acta Gastroenterologica Latinoamericana 25, 137-44.
4. Saldi, F., Longanesi, A., Blasi, A., Monello, S., Cestari, R., Missale, G., Corazziari, E., Badiali, G., Pescatori, M., Anastasio, G. (1991): Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy. Italian Journal of Gastroenterology 23 Suppl. 1, 60-3.
5. Bennett, P., Wilkinson, S. (1985): A comparison of psychological and medical treatment of the irritable bowel syndrome. British Journal of Clinical Psychology 24, 215-6.
6. Blanchard, E. B., Greene, B., Scharff, L., Schwarz-McMorris, S. P. (1993): Relaxation training as a treatment for irritable bowel syndrome. Biofeedback and Self Regulation 18, 125-32.
7. Blanchard, E. B., Schwarz, S. P., Suls, J. M., Gerardi, M. A., Scharff, L., Greene, B., Taylor, A. E., Berreman, C., Malamood, H. S. (1992): Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome. Behavioral Research and Therapy 30, 175-89.
8. Blanchard, E. B., Scharf, L., Schwarz, S. P., Suls, J. M., Barlow, D. H. (1990): The role of anxiety and depression in the irritable bowel syndrome. Behavioral Research and Therapy 28, 401-405.
9. Blewett, A., Allison, M., Calkraft, B., Moore, R., Jenkons, P., Sullivan, G. (1996): Psychiatric disorder and outcome in irritable bowel syndrome. Psychosomatics 37, 155-160.
10. Boemer, R. J. (1997): Die Panikstörung. Diagnose und Behandlung. Stuttgart: Schattauer.
11. Bonelli, J. (1984): Mepindolol sulfate in the hyperkinetic heart syndrome. Int. J. Clin. Pharmacological Therapy and Toxicology 22, 42-44.
12. Cann, P. A., Read, N. W., Holdsworth, C. D. (1983): Oral Domperidone: double blind comparison with placebo in irritable bowel syndrome. Gut 24, 1135-40.
13. Centonze, V., Imbimbo, B. P., Campanozzi, F., Attolini, E., Daniotti, S., Albano, O. (1988): Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome. American Journal of Gastroenterology 83, 1262-6.
14. Cohlan, S. Q., Stone, S. M. (1984): The cough and the bedsheet. Pediatrics 74, 11-5.
15. Corney, R. H., Stanton, R., Newell, R., Clare, A., Fairclough, P. (1991): Behavioural psychotherapy in the treatment of irritable bowel syndrome. Journal of Psychosomatic Research 35, 461-9.
16. Creed, F. (1995): Psychological treatment of irritable bowel syndrome and abdominal pain. In: Mayou, R., Bass, C., Sharpe, M. (Hrsg.) Treatment of Functional Somatic Symptoms, S. 255-270. Oxford: Oxford University Press.
17. Dew, M. J., Evans, B. K., Rhodes, J. (1984): Peppermint oil for the irritable bowel syndrome: a multicentre trial. British Journal of Clinical Practitioning 38, 394-398.
18. Drossman, D. A., McKee, D. C., Sandler, R. S. (1988): Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 95, 701-708.
19. Drossman, D. A., Sandler, R. S., McKee, D. C., Lovitz, A. J. (1982): Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 83, 529-534.
20. Drossman, D. A., Thompson, W. G. (1992): The irritable bowel syndrome: Review and a graduated multicomponent treatment approach. Annals Internal Medicine 116, 1009-1016.
21. Dumitrascu, D. I., Baran, A. (1991): Irritable bowel syndrome complaints following the uprising of December 1989 in Romania. Medicine and War 7, 100-104.
22. Ferrari, A., Cavallero, M., Spandre, M., Gemme, C., Rossini, F. P., Imbimbo, B. P. (1986): Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome. Clinical Therapy, 8, 320-8.
23. Fielding, J. F. (1980): Double blind trial of trimebutine in the irritable bowel syndrome. Irish Medical Journal 73, 377-9.
24. Fielding, J. F. (1982): Domperidone treatment in the irritable bowel syndrome. Digestion 23, 125-7.
25. Fioramonti, J., Fexinos, J., Staumont, G., Bueno, L. (1988): Inhibition of the colonic motor response to eating by pinaverium bromide in irritable bowel syndrome patients. Fundaments of Clinical Pharmacology 2, 19-27.
26. Fiorentini, C., Olivari, M. T., Moruzzi, P., Guazzi, M. D. (1981): Long-term follow-up of the primary hyperkinetic heart syndrome. An echocardiographic and hemodynamic study. American Journal of Medicine 71, 221-7.
27. Fogari, R., Zoppi, A., Corradi, L., Pasotti, C., Malamani, G. D., Gradnik, R., Bokor, D., Gala, C. (1992): Comparison of bisoprolol and diazepam in the treatment of cardiac neurosis. Cardiovascular Drug Therapy 6, 249-53.
28. Folgering, H., Cox, A. (1981): Beta-blocker therapy with metoprolol in the hyperventilation syndrome. Respiration 41, 33-8.
29. Folgering, H., Rutten, H., Roumen, Y. (1983): Beta-blockade in the hyperventilation syndrome. A retrospective assessment of symptoms and complaints. Respiration 44, 19-35.
30. Fowlie, S., Eastwood, M. A., Prescott, R. (1992): Irritable bowel syndrome: assessment of psychological disturbance and its influence on the response to fibre supplementation. Journal of Psychosomatic Research 36, 175-80.
31. Freud, S. (1895): Über die Berechtigung, von der Neurasthenie einen bestimmten Symptomenkomplex als "Angstneurose" abzutrennen. In: GW, Bd.6, S. 25-34. Frankfurt: Fischer.
32. Greenbaum, D. S., Mayle, J. E., Vanegeren, L. E., Jerome, J. A., Mayor, J. W., Greenbaum, R. B., Matson, R. W., Stein, G. E., Dean, H. A., Halvorsen, N. A., Rosen, L. W. (1987): Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Dig. Dis. Sci. 32, 257-66.
33. Greene, B., Blanchard, E. B. (1994): Cognitive Therapy for irritable bowel syndrome. Journal of Consulting Clinical Psychology 62, 576-582.
34. Guthrie, E., Creed, F., Dawson, D., Tomenson, B. (1991): A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 100, 450-7.
35. Harvey, R. F., Hinton, R. A., Gunary, R. M., Barry, R. E. (1989): Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet 1, 424-5.
36. Heaton, K. W., Parker, D., Crips, H. (1993): Bowel function and irritable bowel symptoms after hysterectomy and cholecystectomy - A population based study. Gut 34, 1108-1111.
37. Hislop, I. G. (1971): Psychological significance of the irritable colon syndrome. Gut 12, 452-457.
38. Hoes, M. J., Colla, P., Folgering, H. (1980): Clomipramine treatment of hyperventilation syndrome. Pharmakopsychiatr. Neuropsychopharmacology 13, 25-8.
39. Holtmann, G., Enck, P. (1991): Stress and gastrointestinal motility in humans: A review of the literature. Journal of Gastrointestinal Motility 3, 245-254.
40. Hosaka, T., Yamamoto, K., Ikeda, K., Taniyama, F., Yanagisawa, J. (1995): Application of the relaxation technique in general hospital psychiatry. Psychiatry and Clinical Neurosciences 49, 259-62.
41. Hotz, J., Plein, K. (1994): Wirkung von Plantago-Samenschalen im Vergleich zu Weizenkleie auf Stuhlfrequenz und Beschwerden beim Colon-irritabile-Syndrom mit Obstipation. Medizinische Klinik 89, 645-51.
42. Jalihal, A., Kurian, G. (1990): Ispaghula therapy in irritable bowel syndrome: improvement in overall well-being is related to reduction in bowel dissatisfaction. Journal of Gastroenterology and Hepatology 5, 507-13.
43. Klimes, I. (1990): Psychological treatment for atypical non-cardiac chest pain: a controlled evaluation. Psychological Medicine 20, 605-611.
44. Kruis, W., Weinzierl, M., Schussler, P., Holl, J. (1986): Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome. Digestion 34, 196-201.
45. Kunze, M., Seidel, H. J., Stube, G. (1990): Vergleichende Untersuchungen zur Effektivität der kleinen Psychotherapie, der Akupunktur und der Papaverintherapie bei Patienten mit Colon irritabile. Zeitschrift für die Gesamte Innere Medizin 45, 625-7.
46. Lanfranchi, G. A., Bazzocchi, G., Campieri, M., Brignola, C., Fois, F., Imbimbo, B. P. (1988): Reduction by cimetropium bromide of the co-Ionic motor response to eating in patients with the irritable bowel syndrome. European Journal of Clinical Pharmalogy 33, 571-5.
47. Lavö, B., Stenstam, M., Nielsen, A. L. (1987): Loperamide in treatment of irritable bowel syndrome-a double-blind placebo controlled study. Scandinavian Journal of Gastroenterology 130 Suppl., 77-80.
48. Lucey, M. R., Clark, M. L., Lowndes, J., Dawson, A. M. (1987): Is bran efficacious in irritable bowel syndrome? A double-blind placebo controlled cross-over study. Gut 28, 221-5.
49. Lüttecke, K. (1980): A three-part controlled study of trimebutine in the treatment of irritable colon syndrome. Current Medical Research opinion 6, 437-43.
50. Lydiard, R. B., Fossey, M. D., Marsh, W., Ballenger, J. C. (1993): Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics 34, 229-234.
51. Lynch, P. M., Zamble, E. (1989): A controlled behavioral treatment study of Irritable Bowel Syndrome. Behavioral Therapy 20, 509-523.
52. Martin, M. R., Schiff, A. A. (1994): Fluphenazine/nortriptyline in the irritable bladder syndrome. A double-blind placebo controlled study. British Journal of Urology 56, 178-9.
53. Milo, R. (1980): Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome. Current Medical Research Opinion 6, 577-84.
54. Misra, S. P., Thorat, V. K., Sachdev, G. K., Anand, B. S. (1989): Long-term treatment of irritable bowel syndrome: results of a randomized controlled trial. Quarterly Journal of Medicine 73, 931-9.
55. Myren, J., Groth, H., Larssen, S. E., Larsen, S. (1982): The effect of trimipramine in patients with the irritable bowel syndrome. A double-blind study. Scandinavian Journal of Gastroenterology 17, 871-5.
56. Myren, J., Lovland, B., Larssen, S. E., Larsen, S. (1984): A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome. Scandinavian Journal of Gastroenterology 19, 835-43.
57. Nash, P., Gould, S. R., Bernardo, D. E. (1986): Peppermint oil does not relieve the pain of irritable bowel syndrome. British Journal of Clinical Practice 40, 292-3.
58. Neff, D. F., Blanchard, E. B. (1987): A multi-component treatment for irritable bowel syndrome. Behavioral Therapy 18, 70-83.
59. Nutzinger, D. O. (1987): Panikattacken und Herzphobie. Wiener Klinische Wochenschrift 99, 554-560.
60. Arbeitskreis OPD (Hrsg.) Grundlagen und Manual. Operationalisierte Psychodynamische Diagnostik (1996): S. 74-84. Bern: Huber.
61. Paulley, J. W. (1984): The Psychological Management of the Irritable Colon. Hepato-Gastroenterology 30, 53-54.
62. Paulsen, H. F., Felder, K. (1983): Wirkdauer von beta-Blockern beim hyperkinetischen Herzsyndrom. Zeitschrift für Allgemeinmedizin 59, 1149-54.
63. Payne, A., Blanchard, E. B. (1995): A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. Journal of Consulting and Clinical Psychology 63, 779-786.
64. Prior, A., Whorwell, P. J. (1989): Gynaecological consultations in patients with the irritable bowel syndrome. Gut 30, 996-998.
65. Prout, B. J. (1983): The treatment of irritable bowel syndrome. Two doses of mebeverine compared. Practitioner 227, 1608-8.
66. 21973): Herzneurose. Stuttgart: Thieme.
67. Ritchie, J. A., Truelove, S. C. (1980): Comparison of various treatments for irritable bowel syndrome. BMJ 281, 1317-9.
68. Rutherford, A. J., Hinshaw, K., Essenhigh, D. M., Neal, D. E. (1988): Urethral dilatation compared with cystoscopy alone in the treatment of women with recurrent frequency and dysuria. British Journal of Urology 61, 500-4.
69. Sasaki, T., Takekoshi, T., Okada, T. (1985): Results of prifinium bromide therapy in irritable bowel syndrome. Clinical Therapy 7, 512-21.
70. Schäfer, E., Ewe, K. (1990): Behandlung des Colon irritabile. Wirksamkeit und Verträglichkeit von Buscopan plus, Buscopan, Paracetamol und Plazebo bei ambulanten Patienten mit Colon irritabile. Fortschritte der Medizin 108, 488-92.
71. Schräder, R., Degoutrie, G., Landgraf, H., Kaltenbach, M. (1987): Behandlung des hyperkinetischen Herzsyndroms mit Alinidine und Propanolol. Klinische Wochenschrift 65, 69-75.
72. Schüffel, W., Loew, T., Enck, P., Uexküll v., T. (1996): Funktionelle Syndrome im gastrointestinalen Bereich. In: Uexküll v., T., Adler, R. H., Hermann, J. M., Köhle, K., Schonecke, O. W., Wesiack, W. (Hrsg.): Psychosomatische Medizin, S. 701-712. München: Urban & Schwarzenberg.
73. Shaw, G., Srivastava, E. D., Sadlier, M., Swann, P., James, J. Y., Rhodes, J. (1991): Stress management for irritable bowel syndrome: a controlled trial. Digestion 50, 36-42.
74. Sloth, H., Jorgensen, L. S. (1989): Predictors for the course of chronic non-organic upper abdominal pain. Scandinavian Journal of Gastroenterology 24, 440-444.
75. Stanek, B., Reiterer, W., Placheta, P., Raberger, G. (1983): Acute effects of alinidine on heart rate and blood pressure in healthy subjects and patients with hyperkinetic heart syndrome. European Journal of Clinical Pharmacology 24, 31-4.
76. Stermer, E., Bar, H., Levi, N. (1986): Chronic functional gastrointestinal symptoms in Holocaust survivors. American Journal of Gastroenterology 86, 417-422.
77. Sulz, S. K. (1986): Verhaltenstherapie der Herzphobie - ein klinischer Erfahrungsbericht über ein Training kognitiver Angstbewältigung. Psychiatrische Praxis 13, 10-6.
78. Svedlund, J., Sjodin, I., Ottoson, J. O., Dotevall, G. (1983): Controlled study of psychotherapy in irritable bowel syndrome. Lancet 2, 589-92.
79. Toner, B. B., Garfinkel, P. E., Jeejeebhoy, K. N., Scher, H., Shulhan, D., Gasbarro, I. D. (1990): Self-schema in irritable bowel syndrome and depression. Psychosomatic Medicine 52, 149-155.
80. Tudor, G. J. (1986): A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome. British Journal of Clinical Practice 40, 276-8.
81. 51996): Funktionelle Syndrome. In: Üexküll v., T., Adler, R. H., Hermann, J. M., Köhle, K., Schonecke, O. W., Wesiack, W. (Hrsg.): Psychosomatische Medizin, S. 503-517, München: Urban & Schwarzenberg.
82. Van De Ven, L. L., Mouthaan, B. J., Hoes, M. J. (1995): Treatment of the hyperventilation syndrome with bisoprolol: a placebo-controlled clinical trial. Journal of Psychosomatic Research 39, 1007-13.
83. Van Dorn, P., Folgering, H., Colla, P. (1982): Control of the end-tidal PCO2 in the hyperventilation syndrome: effects of biofeed-back and breathing instructions compared. Bulletin of European Physiopathology and Respiration 18, 829-36.
84. Walker, E. A., Roy Byrne, P. P., Kanton, W. J., Li, L. (1990): Irritable bowel syndrome and psychiatric illness. American Journal of Psychiatry 147, 565-572.
85. Whitehead, W. E., Bosmajian, L., Zonderman, A. B., Costa, P. T., Schuster, M. M. (1988): Symptoms of Psychological Distress Associated with Irritable Bowel Syndrome/Comparison of Community and Medical Clinic Samples. Gastroenterology 95, 709-714.
86. Whitehead, W. E. (1992): Behavioral medicine approaches to gastro-intestinal disorders. Journal of Consulting and Clinical Psychology 60, 605-612.
87. Whorwell, P. J., Prior, A., Colgan, S. M. (1987): Hypnotherapy in severe irritable bowel syndrome: Further experience. Gut 28, 423-425.
88. Whorwell, P. J., Prior, A., Faragher, E. B. (1984): Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 2, 1232-4.
89. Wolff, P. S. (1988): An ingenious way to treat psychogenic cough. American Journal of Maternity and Child Nursing 13, 118-20.